Woodline Partners LP Karyopharm Therapeutics Inc. Transaction History

Woodline Partners LP

  • $11 Billion
  • Q3 2024

A detailed history of Woodline Partners LP transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Woodline Partners LP holds 134,112 shares of KPTI stock, worth $93,878. This represents 0.0% of its overall portfolio holdings.

Number of Shares
134,112
Previous 134,112 -0.0%
Holding current value
$93,878
Previous $116,000 4.31%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$0.72 - $1.66 $12,523 - $28,874
17,394 Added 14.9%
134,112 $202,000
Q4 2023

Feb 14, 2024
SELL
$0.68 - $1.31 $11,827 - $22,786
-17,394 Reduced 12.97%
116,718 $100,000
Q3 2023

Nov 14, 2023
BUY
$1.14 - $1.81 $152,887 - $242,742
134,112 New
134,112 $179,000
Q4 2022

Feb 14, 2023
SELL
$2.48 - $5.93 $467,170 - $1.12 Million
-188,375 Reduced 12.45%
1,324,884 $4.5 Million
Q3 2022

Nov 14, 2022
BUY
$4.08 - $5.82 $6.17 Million - $8.81 Million
1,513,259 New
1,513,259 $8.26 Million
Q3 2020

Nov 16, 2020
SELL
$14.14 - $19.71 $6.55 Million - $9.13 Million
-463,235 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$16.6 - $25.25 $7.69 Million - $11.7 Million
463,235 New
463,235 $8.77 Million
Q1 2020

May 15, 2020
SELL
$14.38 - $27.72 $549,143 - $1.06 Million
-38,188 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$9.23 - $19.67 $352,475 - $751,157
38,188 New
38,188 $732,000

Others Institutions Holding KPTI

# of Institutions
98
Shares Held
57.6M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $55.9M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email